Figure 3From: Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study Absolute CD4+ counts (cells/mm3 ) for the total intent-to-treat population (X ), and for the treatment-naive (♦), restart (■) and switch (▲) sub-group.Back to article page